Home Amines 93413-46-8
93413-46-8,MFCD07369692
Catalog No.:AA0063I7

93413-46-8 | 1-[(1R)-2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL]CYCLOHEXANOL

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
2 weeks  
$2,031.00   $1,422.00
- +
25mg
2 weeks  
$5,041.00   $3,529.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA0063I7
Chemical Name:
1-[(1R)-2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL]CYCLOHEXANOL
CAS Number:
93413-46-8
Molecular Formula:
C17H27NO2
Molecular Weight:
277.4018
MDL Number:
MFCD07369692
SMILES:
COc1ccc(cc1)[C@@H](C1(O)CCCCC1)CN(C)C
Properties
Properties
 
Form:
Solid  
MP:
100-102˚C   
Storage:
2-8℃;  

Computed Properties
 
Complexity:
279  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Heavy Atom Count:
20  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
5  
XLogP3:
2.9  

Literature

Title: Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.

Journal: International journal of pharmaceutics 20120415

Title: Antidepressants and advertising: psychopharmaceuticals in crisis.

Journal: The Yale journal of biology and medicine 20120301

Title: Development and validation of a HPLC-MS/MS method for the determination of venlafaxine enantiomers and application to a pharmacokinetic study in healthy Chinese volunteers.

Journal: Biomedical chromatography : BMC 20110301

Title: Postdischarge impact of C-L psychiatry treatment in obstetrical inpatients.

Journal: ISRN obstetrics and gynecology 20110101

Title: Cerebral venous thrombosis associated with homozygous factor V Leiden mutation in a 15-year-old girl of Tunisian origin.

Journal: Annals of Saudi medicine 20110101

Title: Pollution by psychoactive pharmaceuticals in the Rivers of Madrid metropolitan area (Spain).

Journal: Environment international 20100201

Title: Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study.

Journal: BMJ (Clinical research ed.) 20100101

Title: Development and validation of an ultra performance liquid chromatography method for venlafaxine hydrochloride in bulk and capsule dosage form.

Journal: Indian journal of pharmaceutical sciences 20100101

Title: Comparison of pharmacokinetic profiles of brand-name and generic formulations of citalopram and venlafaxine: a crossover study.

Journal: The Journal of clinical psychiatry 20090701

Title: The relationship between concurrent substance use disorders and eating disorders with personality disorders.

Journal: International journal of environmental research and public health 20090701

Title: Fabrication of triple-layer matrix tablets of venlafaxine hydrochloride using xanthan gum.

Journal: AAPS PharmSciTech 20090601

Title: [Multidrug intoxication].

Journal: Annales de biologie clinique 20090101

Title: Duloxetine for the treatment of generalized anxiety disorder: a review.

Journal: Neuropsychiatric disease and treatment 20090101

Title: Electroencephalographic correlates of Chronic Fatigue Syndrome.

Journal: Behavioral and brain functions : BBF 20090101

Title: Standardized natural product cannabis in pain management and observations at a Canadian compassion society: a case report.

Journal: Cases journal 20090101

Title: Preferred drug lists: potential impact on healthcare economics.

Journal: Vascular health and risk management 20080401

Title: Modulation of venlafaxine hydrochloride release from press coated matrix tablet.

Journal: Indian journal of pharmaceutical sciences 20080101

Title: RP-HPLC Estimation of Venlafaxine Hydrochloride in Tablet Dosage Forms.

Journal: Indian journal of pharmaceutical sciences 20080101

Title: Hair analysis by LC-MS as evidence of nalbuphine abuse by a nurse.

Journal: Journal of analytical toxicology 20070101

Title: Sleep characteristics of persons with chronic fatigue syndrome and non-fatigued controls: results from a population-based study.

Journal: BMC neurology 20060101

Title: Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy.

Journal: Anti-cancer drugs 20050601

Title: [The current challenges of the treatment of depression: venlafaxina extended release and remission outcomes in real-world clinical practice].

Journal: Actas espanolas de psiquiatria 20050101

Title: Antidepressant medication use among First Nations peoples residing within British Columbia.

Journal: American Indian and Alaska native mental health research (Online) 20041105

Title: Is Effexor more effective for depression than an SSRI?

Journal: The Medical letter on drugs and therapeutics 20040216

Title: Venlafaxine hydrochloride for the treatment of hot flashes.

Journal: The Annals of pharmacotherapy 20031101

Title: Protection against oxaliplatin acute neurosensory toxicity by venlafaxine.

Journal: Anti-cancer drugs 20030701

Title: Role of CYP2D6 in the stereoselective disposition of venlafaxine in humans.

Journal: Pharmacogenetics 20030101

Title: Disposition of venlafaxine enantiomers in rats with hepatic encephalopathy after chronic drug treatment.

Journal: Chirality 20020505

Title: Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials.

Journal: Journal of the American Geriatrics Society 20020101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:93413-46-8 Molecular Formula|93413-46-8 MDL|93413-46-8 SMILES|93413-46-8 1-[(1R)-2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL]CYCLOHEXANOL